hematoxylin has been researched along with Familial Nonmedullary Thyroid Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Craig, S; Eszlinger, M; Itani, D; Khalil, M; Koebel, M; Koro, K; Minoo, P; Ogilvie, T; Pasieka, JL; Stewardson, P; Teman, C; Ziehr, B | 1 |
| Cunha, LL; da Assumpção, LV; de Matos, PS; Ferreira, Rde C; Ward, LS | 1 |
2 other study(ies) available for hematoxylin and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts.
Topics: Adenocarcinoma, Follicular; Adult; Biomarkers, Tumor; Biopsy, Fine-Needle; Cohort Studies; Coloring Agents; Consensus; Diagnosis, Differential; Eosine Yellowish-(YS); Hematoxylin; Humans; Immunohistochemistry; Molecular Diagnostic Techniques; Observer Variation; Point Mutation; Staining and Labeling; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms | 2021 |
Both gender and concurrent chronic lymphocytic thyroiditis may influence the nuclear texture of papillary thyroid carcinomas cells.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Cell Nucleus; Chromatin; Eosine Yellowish-(YS); Female; Hashimoto Disease; Hematoxylin; Heterochromatin; Humans; Male; Middle Aged; Sex Factors; Staining and Labeling; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2014 |